SCHEMBL765792

SCHEMBL765792

C/C=C/CCCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016465 1.00
SCHEMBL64720 1.00
SCHEMBL8003221 0.92
SCHEMBL1017304 0.92
SCHEMBL5853223 0.90 ALDH1A1 (0.43)
SCHEMBL5854733 0.90 ALDH1A1 (0.43)
SCHEMBL1017052 0.90 ALDH1A1 (0.43)
SCHEMBL5853219 0.90 ALDH1A1 (0.43)
SCHEMBL7119152 0.90 ALDH1A1 (0.43)
SCHEMBL5854738 0.90 ALDH1A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005742-B2 Method for producing epoxy compound containing hydrogen peroxide stabilizer NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-06-26 US disclosed
US-20170275258-A1 METHOD FOR PRODUCING EPOXY COMPOUND CONTAINING HYDROGEN PEROXIDE STABILIZER NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-09-28 US disclosed
US-9464074-B2 Method for producing epoxy compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-11 US disclosed
US-20150284372-A1 METHOD FOR PRODUCING EPOXY COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-10-08 US disclosed
US-8841285-B2 Potent immunosuppressive agents, derivatives and uses THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-09-23 US disclosed
EP-2487149-A1 METHOD FOR PRODUCING KETONE JX Nippon Oil & Energy Corporation (JP) 2012-08-15 EP disclosed
US-20120197036-A1 METHOD FOR MANUFACTURING KETONE OSAKA UNIVERSITY (JP) 2012-08-02 US disclosed
EP-2098583-B1 Optically isotropic liquid crystal medium and optical device JNC CORP (JP) 2012-03-21 EP disclosed
EP-2360229-A1 OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL ELEMENT JNC Corporation (JP) 2011-08-24 EP disclosed
EP-2028253-B1 Optically isotropic liquid crystal medium and optical device JNC CORP (JP) 2011-08-03 EP disclosed
US-20110002884-A1 THERAPEUTIC COMPOUNDS MERCK SHARP & DOHME LLC 2011-01-06 US disclosed
WO-2009117594-A1 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-09-24 WO disclosed
WO-2009064975-A1 QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-05-22 WO disclosed
US-7230021-B2 Potent, simplified derivatives of pateamine A THE TEXAS A&M UNIVERSITY SYSTEM (US) 2007-06-12 US disclosed